<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-9940</journal-id>
<journal-title><![CDATA[Archivos de cardiología de México]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Cardiol. Méx.]]></abbrev-journal-title>
<issn>1405-9940</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Cardiología Ignacio Chávez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-99402016000400326</article-id>
<article-id pub-id-type="doi">10.1016/j.acmx.2015.12.003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La diabetes y la alimentación determinantes en la progresión de aterosclerosis]]></article-title>
<article-title xml:lang="en"><![CDATA[Diabetes and type of diet as determinant factor in the progression of atherosclerosis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perales-Torres]]></surname>
<given-names><![CDATA[Adriana Leticia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo-Ruíz]]></surname>
<given-names><![CDATA[Octelina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castañeda Licón]]></surname>
<given-names><![CDATA[María Teresa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alemán-Castillo]]></surname>
<given-names><![CDATA[Sanjuana E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jiménez Andrade]]></surname>
<given-names><![CDATA[Juan Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad Autónoma de Tamaulipas Departamento de Nutrición y Alimentos ]]></institution>
<addr-line><![CDATA[Reynosa Tamaulipas]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidad Autónoma de Tamaulipas Departamento de Farmacología ]]></institution>
<addr-line><![CDATA[Matamoros Tamaulipas]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Universidad Autónoma de Tamaulipas Departamento de Farmacología ]]></institution>
<addr-line><![CDATA[Reynosa Tamaulipas]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>86</volume>
<numero>4</numero>
<fpage>326</fpage>
<lpage>334</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-99402016000400326&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-99402016000400326&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-99402016000400326&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El propósito de esta revisión es analizar la progresión bioquímica de la placa aterosclerótica y la relación que presenta con la diabetes y la alimentación. Se exponen las evidencias científicas de pacientes con diabetes, que a diferencia de pacientes no diabéticos presentan niveles más elevados de algunos ácidos grasos en la placa de ateroma (como el palmítico, linoleico y oleico), elevada incidencia de trombosis coronaria relacionada con el incremento en el tamaño de la base necrótica y la disminución del tamaño de la capa fibrosa de los ateromas. Entre ambos grupos de pacientes se expone la diferencia en el perfil de lípidos de la placa aterosclerótica, así como los cambios celulares involucrados en la formación de la misma y la influencia de la alimentación sobre su desarrollo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract The purpose of this review is to analyze the biochemical progression of atherosclerotic plaque and its association with diet and diabetes. This study shows the scientific evidence of demonstrating that diabetic patients present high levels of fatty acids like palmitic acid and linoleic acid in their atheroma plaques in comparison with non-diabetic patients. This study also establishes how patients with diabetes mellitus have a higher prevalence of atherosclerotic heart diseases in the form of Coronary Thrombosis and have different anatomopathological appearance like higher necrotic core and thin fibrotic layer than the general population. Furthermore this review describes the different anatomopathological appearance and cellular changes involved in the formation of these plaques and how diet can affect the development of these plaques.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Aterosclerosis]]></kwd>
<kwd lng="es"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[Alimentación]]></kwd>
<kwd lng="es"><![CDATA[Ácidos grasos]]></kwd>
<kwd lng="es"><![CDATA[México]]></kwd>
<kwd lng="en"><![CDATA[Atherosclerosis]]></kwd>
<kwd lng="en"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[Food intake]]></kwd>
<kwd lng="en"><![CDATA[Fatty acids]]></kwd>
<kwd lng="en"><![CDATA[Mexico]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hyperglycemia and endothelial dysfunction in atherosclerosis Lessons from type 1 diabetes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Funk]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Yurdagul Jr]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Orr]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Vasc Med]]></source>
<year>2012</year>
<volume>2012</volume>
<page-range>569-654</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Standards of medical care in diabetes 2012]]></article-title>
<collab>American Diabetes Association</collab>
<source><![CDATA[Diabetes Care]]></source>
<year>2012</year>
<volume>35</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S11-63</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Report of the committee on the classification and diagnostic criteria of diabetes mellitus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seino]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nanjo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<collab>Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus</collab>
<source><![CDATA[J Diabetes Investig]]></source>
<year>2010</year>
<volume>1</volume>
<page-range>212-28</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<source><![CDATA[Diabetes FID. Atlas de la diabetes de la F.I.D]]></source>
<year>2013</year>
<edition>6</edition>
<page-range>1-153</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Diabetes tipo 2]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvillo-Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Barrientos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Epidemiología. Boletín epidemiológico 2013]]></source>
<year>2013</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Envejecimiento de la población un reto para la salud pública]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berrío-Valencia]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Colomb Anestesiol]]></source>
<year>2012</year>
<volume>40</volume>
<page-range>192-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diabetes mellitus en ancianos, caracterización epidemiológica y comportamiento clínico terapéutico en San Antonio de los Baños]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canciano-Chirino]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Reinoso-Pérez]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Martínez]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Haban Cienc Méd]]></source>
<year>2011</year>
<volume>10</volume>
<page-range>54-60</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<source><![CDATA[Diabetes. Organización Mundial de la Salud]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-serial angioscopic and intravascular ultrasound analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takayama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hiro]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ueda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<source><![CDATA[J Cardiol]]></source>
<year>2013</year>
<volume>61</volume>
<page-range>381-6</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[La lesión aterosclerótica en la muerte súbita cardiaca]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa-Montes]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[González-Lugo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tamayo-Vicente]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Haban Cienc Méd]]></source>
<year>2010</year>
<volume>9</volume>
<page-range>303-12</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidencia de las dislipidemias y su relación con la cardiopatía isquémica en la población del Policlínico Héroes del Moncada]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cabalé-Vilariño]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Meneau]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cubana Med Gen Integr]]></source>
<year>2005</year>
<volume>21</volume>
<numero>5-6</numero>
<issue>5-6</issue>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Vascular complications of diabetes: Mechanisms of injury and protective factors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rask-Madsen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[GL.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cell Metab]]></source>
<year>2013</year>
<volume>17</volume>
<page-range>20-33</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Monounsaturated fatty acid, carbohydrate intake, and diabetes status are associated with arterial pulse pressure]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vaccaro]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Huffman]]></surname>
<given-names><![CDATA[FG]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutr J]]></source>
<year>2011</year>
<volume>10</volume>
<page-range>126</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<source><![CDATA[Enfermedades cardiovasculares]]></source>
<year>2015</year>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="">
<source><![CDATA[Cardiovascular disease terms]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Arteriosclerosis Rethinking the current classification]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Fishbein]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Pathol Lab Med]]></source>
<year>2009</year>
<volume>133</volume>
<page-range>1309-16</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Fisiopatología de la ateroesclerosis, primera parte]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suárez-Loaiza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Costarric Cardiol]]></source>
<year>2001</year>
<volume>3</volume>
<page-range>54-63</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peralta]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
</person-group>
<source><![CDATA[Diabetes mellitus tipo II y aterosclerosis]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Rosario ]]></publisher-loc>
<publisher-name><![CDATA[Wiener Laboratorios]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[El papel de la inflamación en la aterogénesis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mago]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rosa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Invest Clin]]></source>
<year>2009</year>
<volume>50</volume>
<page-range>109-29</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Biomarkers in cardiovascular medicine]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin-Ventura]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Blanco-Colio]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Tunon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2009</year>
<volume>62</volume>
<page-range>677-88</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiología inversa baja concentración de LDL modificadas y morbimortalidad cardiovascular en pacientes con hemodiálisis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wikinski]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cacciagiú]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Bioquím Clín Latinoam]]></source>
<year>2013</year>
<volume>47</volume>
<page-range>95-100</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Mecanismos básicos Regulación y aclaramiento de las lipoproteínas que contienen apolipoproteína B]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Gonzalo-Calvo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Revuelta-López]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Llorente-Cortés]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Invest Arterioscl]]></source>
<year>2013</year>
<volume>25</volume>
<page-range>194-200</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aterosclerosis, inflamación e intervenciones, prevención, estabilización y regresión de la placa]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruiz-Morales]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Peru Cardiol]]></source>
<year>2007</year>
<volume>33</volume>
<page-range>87-95</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Los ácidos grasos omega-3 en la promoción de la salud y la prevención de las enfermedades crónicas (1 a parte: el sistema cardiovascular)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Javierre]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de Flores]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Obes]]></source>
<year>2007</year>
<volume>5</volume>
<page-range>39-59</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aterosclerosis y lesión endotelial ¿proceso irreversible]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bourlon-Cuéllar]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[López-Nuche]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Med Int Mex]]></source>
<year>2010</year>
<volume>26</volume>
<page-range>590-6</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Colesterol HDL y su papel en la ateroesclerosis ¿unde venis, quo vadis?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Santos-Gallego]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de Miguel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ibañez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2008</year>
<volume>37</volume>
<page-range>94-105</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[N-3 vs saturated fatty acids: Effects on the arterial wall]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sudheendran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Deckelbaum]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Prostaglandins, leukotrienes, and essential fatty acids]]></source>
<year>2010</year>
<volume>82</volume>
<page-range>205-9</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Progress in atherosclerotic plaque imaging]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soloperto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Casciaro]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Radiol]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>353-71</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Atherosclerosis as a systemic disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lahoz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mostaza]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2007</year>
<volume>60</volume>
<page-range>184-95</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impact of diabetes duration on atheroma progression in diabetic patients with coronary artery disease: Insights from serial intravascular ultrasound]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kataoka]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Shao]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Wolski]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation]]></source>
<year>2011</year>
<volume>24</volume>
<numero>21^sA</numero>
<issue>21^sA</issue>
<supplement>A</supplement>
<page-range>10453</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Morphological characteristics of coronary atherosclerosis in diabetes mellitus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Virmani]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Kolodgie]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2006</year>
<volume>2</volume>
<numero>^sB</numero>
<issue>^sB</issue>
<supplement>B</supplement>
<page-range>81B-4B</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Niveles de moléculas de adhesión solubles en pacientes diabéticos tipo 2 normotensos e hipertensos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rubio-Guerra]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Robles]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Medina-Santillán]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Gac Méd Méx]]></source>
<year>2008</year>
<volume>144</volume>
<page-range>11-4</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo de aterosclerosis en pacientes diabéticos tipo 2]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agramonte-Martínez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Haban Cienc Med]]></source>
<year>2009</year>
<volume>8</volume>
<page-range>342-9</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cardiovascular disease risk in type 2 diabetes mellitus Insights from mechanistic studies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazzone]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Chait]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Plutzky]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2008</year>
<volume>371</volume>
<page-range>1800-9</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuccurullo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Iezzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fazia]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<source><![CDATA[Arterioscler Thromb Vasc Biol]]></source>
<year>2006</year>
<volume>26</volume>
<page-range>2716-23</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques Role of glycemic control]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cipollone]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Iezzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fazia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation]]></source>
<year>2003</year>
<volume>108</volume>
<page-range>1070-7</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Type 2 diabetes and cardiovascular disease Have all risk factors the same strength?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin-Timon]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sevillano-Collantes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Segura-Galindo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[World J Diabetes]]></source>
<year>2014</year>
<volume>5</volume>
<page-range>444-70</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[An integrated view of insulin resistance and endothelial dysfunction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muniyappa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Iantorno]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quon]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Endocrinol Metab Clin North Am]]></source>
<year>2008</year>
<volume>37</volume>
<page-range>685-711</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pathogenesis of insulin resistance in skeletal muscle]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abdul-Ghani]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[DeFronzo]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<source><![CDATA[J Biomed Biotechnol]]></source>
<year>2010</year>
<volume>2010</volume>
<page-range>476279</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Perfil metabólico de riesgo cardiovascular y resistencia a la insulina según índice de masa corporal, circunferencia de cintura y cintura hipertrigliceridémica en pacientes adultos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espinoza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Méd Chile]]></source>
<year>2009</year>
<volume>137</volume>
<page-range>1179-86</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Insulin resistance A proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montecucco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Steffens]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mach]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Mediators Inflamm]]></source>
<year>2008</year>
<volume>2008</volume>
<page-range>767623</page-range></nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Atherogenesis and diabetes Focus on insulin resistance and hyperinsulinemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Madonna]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[de Caterina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Cardiol (Engl Ed)]]></source>
<year>2012</year>
<volume>65</volume>
<page-range>309-13</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[eNOS metabolic syndrome and cardiovascular disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
</person-group>
<source><![CDATA[Trends Endocrinol Metab]]></source>
<year>2009</year>
<volume>20</volume>
<page-range>295-302</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Immunoexpression of angiogenesis and proliferation markers in patients treated with cyclosporin A]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Afonso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Perrotti]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rapani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Minerva Stomatol]]></source>
<year>2014</year>
<volume>63</volume>
<page-range>59-67</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Spontaneously diabetic Ins2(+/Akita) ApoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jun]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Segar]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Physiol Endocrinol Metab]]></source>
<year>2011</year>
<volume>301</volume>
<page-range>E145-54</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Insulin resistance and cardiovascular disease]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ginsberg]]></surname>
<given-names><![CDATA[HN]]></given-names>
</name>
</person-group>
<source><![CDATA[The Journal of Clinical Investigation]]></source>
<year>2000</year>
<volume>106</volume>
<page-range>453-8</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Morphologic findings of coronary atherosclerotic plaques in diabetics A postmortem study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Kolodgie]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Zieske]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Arteriosclerosis, Thrombosis, and Vascular Biology]]></source>
<year>2004</year>
<volume>24</volume>
<page-range>1266-71</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Plaque characterisation by virtual histology intravascular ultrasound analysis in patients with type 2 diabetes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nasu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tsuchikane]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Katoh]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<source><![CDATA[Heart]]></source>
<year>2008</year>
<volume>94</volume>
<page-range>429-33</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques A role for oxidized polyunsaturated fatty acids]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garbin]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Baggio]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stranieri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Cardiovasc Res]]></source>
<year>2013</year>
<volume>97</volume>
<page-range>125-33</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tabas]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Tall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Accili]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation Res]]></source>
<year>2010</year>
<volume>106</volume>
<page-range>58-67</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epicardial and subcutaneous adipose tissue fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pezeshkian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mahtabipour]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<source><![CDATA[BioImpacts: BI]]></source>
<year>2013</year>
<volume>3</volume>
<page-range>83-9</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez-Pinna]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martin-Ventura]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[Diabetes]]></source>
<year>2010</year>
<volume>59</volume>
<page-range>1292-301</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dietary trans fatty acids and composition of human atheromatous plaques]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stachowska]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Dolegowska]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Chlubek]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Nutr]]></source>
<year>2004</year>
<volume>43</volume>
<page-range>313-8</page-range></nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ácidos grasos libres en suero de pacientes diabéticos tipo 2]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrizales]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leal-de García]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[INFORMED]]></source>
<year>2008</year>
<volume>10</volume>
<page-range>59-66</page-range></nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grapov]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[TL]]></given-names>
</name>
</person-group>
<source><![CDATA[PloS One]]></source>
<year>2012</year>
<volume>7</volume>
<page-range>e48852</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[HDL and endothelial protection]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tran-Dinh]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Diallo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Delbosc]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Pharmacol]]></source>
<year>2013</year>
<volume>169</volume>
<page-range>493-511</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Alimentación saludable y nutrición en las enfermedades cardiovasculares]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Socarrás-Suárez]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Bolet-Astoviza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cubana Invest Bioméd]]></source>
<year>2010</year>
<volume>29</volume>
<page-range>353-63</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association of dietary patterns with insulin resistance and clinically silent carotid atherosclerosis in apparently healthy people]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buscemi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolucci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mattina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Clin Nutr]]></source>
<year>2013</year>
<volume>67</volume>
<page-range>1284-90</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haversen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Danielsson]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Fogelstrand]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Atherosclerosis]]></source>
<year>2009</year>
<volume>202</volume>
<page-range>382-93</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The impact of dietary fatty acids on macrophage cholesterol homeostasis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Afonso Mda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castilho]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lavrador]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<source><![CDATA[J Nutr Biochem]]></source>
<year>2014</year>
<volume>25</volume>
<page-range>95-103</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ácidos grasos trans un análisis del efecto de su consumo en la salud humana, regulación del contenido en alimentos y alternativas para disminuirlos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ballesteros-Vásquez]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela-Calvillo]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Artalejo-Ochoa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutr Hosp]]></source>
<year>2012</year>
<volume>27</volume>
<page-range>54-64</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aceites de origen marino; su importancia en la nutrición y en la ciencia de alimentos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valenzuela]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanhueza]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chil Nutr]]></source>
<year>2009</year>
<volume>36</volume>
<page-range>246-57</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evidencias sobre las grasas en la dieta y enfermedad coronaria]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[González-Gallegos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Ruiz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Milke-Nájar]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<source><![CDATA[Salus]]></source>
<year>2009</year>
<volume>10</volume>
</nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Carotid and femoral plaque burden is inversely associated with the alpha-linolenic acid proportion of serum phospholipids in Spanish subjects with primary dyslipidemia]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sala-Vila]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cofan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nunez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Atherosclerosis]]></source>
<year>2011</year>
<volume>214</volume>
<page-range>209-14</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dietary linolenic acid and carotid atherosclerosis The National Heart, Lung, and Blood Institute Family Heart Study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Djousse]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Folsom]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Province]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>2003</year>
<volume>77</volume>
<page-range>819-25</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kasbi Chadli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nazih]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Krempf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>e61109</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Diminished omega-3 fatty acids are associated with carotid plaques from neurologically symptomatic patients Implications for carotid interventions]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bazan]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Thoppil]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Vascul Pharmacol]]></source>
<year>2009</year>
<volume>51</volume>
<page-range>331-6</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Low serum docosahexaenoic acid is associated with progression of coronary atherosclerosis in statin-treated patients with diabetes mellitus results of the treatment with statin on atheroma regression evaluated by intravascular ultrasound with virtual histology (TRUTH) study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nozue]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Yamamoto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tohyama]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Cardiovasc Diabetol]]></source>
<year>2014</year>
<volume>13</volume>
<page-range>13</page-range></nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypercholesterolemia A therapeutic approach]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morais Lopez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lama More]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Dalmau Serra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<collab>Comite de Nutricion de la AEP</collab>
<source><![CDATA[An Pediatr (Barc)]]></source>
<year>2009</year>
<volume>70</volume>
<page-range>488-96</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ácidos grasos con isomería trans i Su origen y los efectos en la salud humana]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valenzuela]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chil Nutr]]></source>
<year>2008</year>
<volume>35</volume>
<page-range>162-71</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevention of cardiovascular diseases Role of exercise, dietary interventions, obesity and smoking cessation]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buttar]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ravi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Exp Clin Cardiol]]></source>
<year>2005</year>
<volume>10</volume>
<page-range>229-49</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Ingesta de alimentos de origen animal versus origen vegetal y riesgo cardiovascular]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pino]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cediel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Chil Nutr]]></source>
<year>2009</year>
<volume>36</volume>
<page-range>210-6</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with type 1 diabetes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tikellis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pickering]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tsorotes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Sci (Lond)]]></source>
<year>2013</year>
<volume>124</volume>
<page-range>617-26</page-range></nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Obesidad, resistencia a la insulina y aumento de los niveles de adipoquinas Importancia de la dieta y el ejercicio físico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Perea]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[López-Sobaler]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<source><![CDATA[Nutr Hosp]]></source>
<year>2009</year>
<volume>24</volume>
<page-range>415-21</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
